Sam Altman's Life Extension Guy Warns of Injections That Cause Wild Tumor Growth
OpenAI CEO Sam Altman has invested a whopping $180 million in a startup that's looking for novel ways to extend human longevity. As Bloomberg, which recently got an insider look at the company, reports, the company called Retro Biosciences has an unusual way of conducting its research, and is investigating not just one area of […]